Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides

Antimicrob Agents Chemother. 2004 Aug;48(8):3162-4. doi: 10.1128/AAC.48.8.3162-3164.2004.

Abstract

The efficacy of linezolid and temporin A in the prevention of prosthetic graft infection due to methicillin-resistant Staphylococcus epidermidis with intermediate resistance to glycopeptides was investigated in a subcutaneous rat pouch model. Linezolid and temporin A, alone or combined, greatly reduced the bacterial numbers compared to the effect with control drugs.

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / therapeutic use*
  • Animals
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Antimicrobial Cationic Peptides
  • Blood Vessel Prosthesis*
  • Colony Count, Microbial
  • Drug Resistance, Bacterial
  • Drug Synergism
  • Glycopeptides / pharmacology*
  • Linezolid
  • Male
  • Microbial Sensitivity Tests
  • Oxazolidinones / administration & dosage
  • Oxazolidinones / therapeutic use*
  • Pharmaceutical Solutions
  • Polyethylene Terephthalates
  • Prosthesis-Related Infections / microbiology
  • Prosthesis-Related Infections / prevention & control*
  • Proteins / administration & dosage
  • Proteins / therapeutic use*
  • Rats
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control*
  • Staphylococcus epidermidis*

Substances

  • Acetamides
  • Anti-Infective Agents
  • Antimicrobial Cationic Peptides
  • Glycopeptides
  • Oxazolidinones
  • Pharmaceutical Solutions
  • Polyethylene Terephthalates
  • Proteins
  • temporin
  • Linezolid